Stay updated on CMB305 in NY-ESO-1+ Cancer: Phase 1b Clinical Trial
Sign up to get notified when there's something new on the CMB305 in NY-ESO-1+ Cancer: Phase 1b Clinical Trial page.

Latest updates to the CMB305 in NY-ESO-1+ Cancer: Phase 1b Clinical Trial page
- Check4 days agoChange DetectedA notice about NIH’s terminology transition appears above the unavailable study record.SummaryDifference1%

- Check11 days agoChange DetectedThe footer’s site revision changes from v3.7.1 to v3.7.2; the page continues to display a 403 error.SummaryDifference0.2%

- Check18 days agoChange DetectedThe site footer revision advances from v3.7.0 to v3.7.1 while the study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check32 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the expected study details with a minimal error page and a Home link. This indicates an access or load issue rather than the trial information.SummaryDifference19%

- Check39 days agoChange DetectedRevision label updated from v3.6.6 to v3.7.0, indicating a new software release for the page. This platform update does not modify the study details, eligibility criteria, or substantive content.SummaryDifference0.1%

- Check53 days agoChange DetectedRevision updated from v3.6.5 to v3.6.6 in the page history, indicating a small, non-substantive update to the page.SummaryDifference0.1%

Stay in the know with updates to CMB305 in NY-ESO-1+ Cancer: Phase 1b Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CMB305 in NY-ESO-1+ Cancer: Phase 1b Clinical Trial page.